Dr. Rosina Samadani has 24 years of experience with medical device companies, including 7 years with McKinsey & Company as a leader in their healthcare practice. This is her 4th startup. She has raised $11M+ from accredited investors, angel groups and venture capital, conducted multiple FDA interactions for disruptive, breakthrough diagnostics via the de novo and 510(k) pathways, led the procurement of $2.5M+ funding via Department of Defense, NIH and FDA contracts and grants, established successful relationships with major research centers and the Department of Defense, and authored multiple patents. Oculogica is the winner of the 2018 Angel Capital Association Luis Villalobos Award for Innovative Startup, and Dr. Samadani was awarded the 2019 NIMBLE Health Vanguard Award for entrepreneurship in healthcare and, along with her sister Dr. Uzma Samadani, to the 2020 Fast Company Most Creative People in Business list. Dr. Samadani has her BS and MS from MIT in Mechanical Engineering, and her PhD in Biomedical Engineering from Northwestern University.